We are pleased to welcome our new colleague Diego Romero to the team!

Inhibitec Antibodies has been selected for the ‘Programa Personal Técnico I+D’, supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN), enabling us to expand our scientific team with the addition of a new R&D technician (RH25-XX-011).

The funding awarded amounts to €17,177.16, representing a funding intensity of 59.15%, with an implementation period from 1 September 2025 to 31 August 2026.

We sincerely appreciate SODERCAN’s continued support for Inhibitec since the early stages of our project.

Share the Post:

Related Posts

We are thrilled to announce the publication of our study, “Humanized anti-BAMBI monoclonal antibody as a novel therapeutic strategy for psoriatic arthritis”, in Journal of...

Inhibitec has received funding ((€3,533.45) through the Planes de Promoción Comercial program (NM25-PC-109), supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN). This grant...

Inhibitec Antibodies has been one of the startups selected in the ‘Programa Personal Tecnico I+D’ supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN)...

Scroll to Top